Novartis has struck a deal to buy…
Novartis has struck a deal to buy Synnovation Therapeutics’ pan-mutant‑selective [...]
Novartis has struck a deal to buy Synnovation Therapeutics’ pan-mutant‑selective [...]
Gilead has handed back a next-gen hepatitis B antiviral to [...]
Renowned cardiologist Eric Topol, M.D., is setting sail with Flagship [...]
Genentech has elected to stop a phase 2 trial of [...]
About a month after Pfizer CEO Albert Bourla, Ph.D., told [...]
Phage-focused BiomX is undergoing a “strategic and financial reset” in [...]
Fauna Bio, which signed an obesity-focused partnership with Lilly back [...]
More than 100 marchers took to Capitol Hill on Wednesday [...]
With the obesity numbers for Eli Lilly’s experimental triple agonist [...]
For children with Dravet syndrome, a rare, severe genetic disease [...]